| Item Type | Name |
|
Academic Article
|
The safety of liposuction: results of a national survey.
|
|
Academic Article
|
Efficacy is more easily assessed than safety.
|
|
Academic Article
|
The safety of office-based surgery: review of recent literature from several disciplines.
|
|
Academic Article
|
Drug Safety.
|
|
Academic Article
|
Detecting adverse events in dermatologic surgery.
|
|
Academic Article
|
Efficacy and safety of calcipotriene 0.005% foam for the treatment of plaque-type psoriasis: results of two multicenter, randomized, double-blind, vehicle-controlled, phase III clinical trials.
|
|
Academic Article
|
A multicenter, randomized, double-blind study of the efficacy and safety of calcipotriene foam, 0.005%, vs vehicle foam in the treatment of plaque-type psoriasis of the scalp.
|
|
Academic Article
|
Efficacy, safety, and cost of office-based surgery: a multidisciplinary perspective.
|
|
Academic Article
|
Strategy to manage the treatment of severe psoriasis: considerations of efficacy, safety and cost.
|
|
Academic Article
|
Why are there differences in the perceived safety of office-based surgery?
|
|
Academic Article
|
Adverse event reporting: lessons learned from 4 years of Florida office data.
|
|
Academic Article
|
Dermatological patient safety: problems and solutions.
|
|
Academic Article
|
A review of home phototherapy for psoriasis.
|
|
Academic Article
|
Efficacy and safety of ustekinumab and etanercept for the treatment of psoriasis.
|
|
Academic Article
|
Commentary: psoriasis patients with a history of malignancy represent an important but overlooked study population.
|
|
Academic Article
|
Long-term safety of ketoconazole foam, 2% in the treatment of seborrheic dermatitis: results of a phase IV, open-label study.
|
|
Concept
|
Safety Management
|
|
Concept
|
Equipment Safety
|
|
Concept
|
Safety
|
|
Academic Article
|
Safety and tolerability of tumor necrosis factor-a inhibitors in psoriasis: a narrative review.
|
|
Academic Article
|
Electrosurgery: part II. Technology, applications, and safety of electrosurgical devices.
|
|
Academic Article
|
Is Safety Psoriasis Patients' Overriding Concern?
|
|
Academic Article
|
To test or not to test? An updated evidence-based assessment of the value of screening and monitoring tests when using systemic biologic agents to treat psoriasis and psoriatic arthritis.
|
|
Academic Article
|
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study.
|
|
Academic Article
|
Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis.
|
|
Academic Article
|
Presenting treatment safety data: subjective interpretations of objective information.
|
|
Grant
|
Hawthorne Conference on Office-Based Surgery
|
|
Academic Article
|
Spotlight on brimonidine topical gel 0.33% for facial erythema of rosacea: safety, efficacy, and patient acceptability.
|
|
Academic Article
|
The safety of treatments used in pyoderma gangrenosum.
|
|
Academic Article
|
A safety review of the medications used to treat atopic dermatitis.
|
|
Academic Article
|
In-office compounding of lidocaine-epinephrine: An option for anesthesia preparation before skin biopsy.
|
|
Academic Article
|
Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative Colitis.
|
|
Academic Article
|
A safety review of recent advancements in the treatment of psoriasis: analysis of clinical trial safety data.
|